These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15842530)

  • 1. Cardiovascular therapies and their role in diabetic eye disease.
    Denniston AK; Banerjee S; Gibson JM; Dodson PM
    Diabet Med; 2005 May; 22(5):665-6. PubMed ID: 15842530
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins and diabetes.
    Hitman GA
    Diabet Med; 2014 Jun; 31(6):639. PubMed ID: 24835891
    [No Abstract]   [Full Text] [Related]  

  • 3. Widespread statin use recommended for patients with type 2 diabetes.
    Voelker R
    JAMA; 2004 May; 291(20):2419-20. PubMed ID: 15161877
    [No Abstract]   [Full Text] [Related]  

  • 4. Statin power.
    Diabetes Forecast; 2008 Apr; 61(4):28. PubMed ID: 18478640
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating dyslipidaemia in the setting of diabetes mellitus and cardiovascular disease: another focus.
    Tahrani AA
    Int J Clin Pract; 2006 Nov; 60(11):1515; author reply 1515-6. PubMed ID: 17073848
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin: not currently for primary prevention in diabetes.
    Jackson G
    Int J Clin Pract; 2009 Jun; 63(6):831-2. PubMed ID: 19490189
    [No Abstract]   [Full Text] [Related]  

  • 7. The under-use of statin in type 2 diabetic patients attending diabetic clinics in Italy.
    Avogaro A; Guida P; Giorda C; Mannucci E; Medea G; Comaschi M; Velussi M; Armienti G; Zucchetti R;
    Nutr Metab Cardiovasc Dis; 2007 Jan; 17(1):32-40. PubMed ID: 17174224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose statins for diabetes.
    Health News; 2006 Aug; 12(8):11. PubMed ID: 16917968
    [No Abstract]   [Full Text] [Related]  

  • 9. Should you put all diabetic patients on statins?
    Leiter LA
    J Fam Pract; 2007 Apr; 56(4):294-300. PubMed ID: 17403328
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
    González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D;
    Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria.
    Nellemann B; Gormsen LC; Dollerup J; Schmitz O; Mogensen CE; Rasmussen LM; Nielsen S
    Diabetes Care; 2007 Dec; 30(12):3122-4. PubMed ID: 17804683
    [No Abstract]   [Full Text] [Related]  

  • 12. Fenofibrate set to benefit from new research on its active metabolite, fenofibric acid.
    Cardiovasc J Afr; 2008; 19(3):171-2. PubMed ID: 18568186
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes and cardiovascular disease.
    Neil A
    Diabetes Obes Metab; 2003 Nov; 5 Suppl 1():S11-8. PubMed ID: 14984017
    [No Abstract]   [Full Text] [Related]  

  • 14. Ways to reduce cardiovascular disease in diabetes.
    Garg SK; DiDomenico D; Switzer S
    Diabetes Technol Ther; 2012 Jun; 14 Suppl 1():S1-2. PubMed ID: 22650219
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).
    Rydén L; Standl E; Bartnik M; Van den Berghe G; Betteridge J; de Boer MJ; Cosentino F; Jönsson B; Laakso M; Malmberg K; Priori S; Ostergren J; Tuomilehto J; Thrainsdottir I; Vanhorebeek I; Stramba-Badiale M; Lindgren P; Qiao Q; Priori SG; Blanc JJ; Budaj A; Camm J; Dean V; Deckers J; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo J; Zamorano JL; Deckers JW; Bertrand M; Charbonnel B; Erdmann E; Ferrannini E; Flyvbjerg A; Gohlke H; Juanatey JR; Graham I; Monteiro PF; Parhofer K; Pyörälä K; Raz I; Schernthaner G; Volpe M; Wood D; ;
    Eur Heart J; 2007 Jan; 28(1):88-136. PubMed ID: 17220161
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes and lipid lowering: where are we?
    Reckless JP
    BMJ; 2006 May; 332(7550):1103-4. PubMed ID: 16690643
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes resources. Getting involved in clinical trials.
    Dairman T
    Diabetes Self Manag; 2004; 21(6):87-9. PubMed ID: 15688471
    [No Abstract]   [Full Text] [Related]  

  • 18. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
    Wienbergen H; Senges J; Gitt AK
    Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
    Goff DC; Gerstein HC; Ginsberg HN; Cushman WC; Margolis KL; Byington RP; Buse JB; Genuth S; Probstfield JL; Simons-Morton DG;
    Am J Cardiol; 2007 Jun; 99(12A):4i-20i. PubMed ID: 17599424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How can we prevent cardiovascular disease in diabetes.
    Wiklund O; Håversen L; Pettersson C; Hultén LM
    J Intern Med; 2007 Aug; 262(2):199-207. PubMed ID: 17645587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.